Hepatitis B
📧 Sign up to get email alerts when something new happens for Hepatitis B.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2009-06-04Clinical Trial Update: Long Term Follow-up Study at Years 2, 3, 4 and 5 Where 2 Dosing Schedules of the Combined Hepatitis A and B Vaccine Were Compared [Phase 3]
A Phase 3 long-term follow-up study comparing two dosing schedules of the combined hepatitis A and B vaccine; results completed with posted …
-
CLINICAL_TRIALS trial_result · 2009-06-03Clinical Trial Update: Validity and Cost-Effectiveness of a New Screening Test for Hepatocellular Carcinoma
A completed clinical trial evaluated the validity and cost-effectiveness of a new screening test for hepatocellular carcinoma in individuals…
-
CLINICAL_TRIALS trial_result · 2009-05-27Clinical Trial Update: Long-term Persistence of Immunity Against Hepatitis B in 7-8 Years Old Children After Hepatitis B Vaccination. [Phase 4]
A phase 4 trial evaluating long-term persistence of immunity in 7- to 8-year-old children following hepatitis B vaccination.
-
CLINICAL_TRIALS trial_result · 2009-05-15Clinical Trial Update: Immune Response to Hepatitis B Vaccine Challenge Dose in Subjects Who Received a Primary Neonatal Hepatitis B Vaccine. [Phase 4]
Phase 4 update evaluating the immune response to a hepatitis B vaccine challenge dose in individuals who previously received a neonatal hepa…
-
CLINICAL_TRIALS trial_result · 2009-05-08Clinical Trial Update: Efficacy and Safety of Intramuscular HBIG Grifols for the Prevention of Recurrence After Liver Transplantation [Phase 2]
A Phase 2 trial assessed the efficacy and safety of intramuscular hepatitis B immune globulin (HBIG) from Grifols for preventing recurrence …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2009-05-08Clinical Trial Update: Safety and Efficacy Study of LB80380 in the Patients With Lamivudine-Refractory Chronic Hepatitis B [Phase 1, Phase 2]
Clinical trial update reporting safety and efficacy data for LB80380 in lamivudine-refractory chronic hepatitis B in a combined Phase 1/2 st…
-
CLINICAL_TRIALS trial_result · 2009-05-06Clinical Trial Update: Safety, Long Term Immunogenicity and Lot Consistency Study of Liquid Pentavalent Combination Vaccine [Phase 4]
This Phase 4 trial reports on long-term safety, immunogenicity, and lot-to-lot consistency for a liquid pentavalent vaccine covering diphthe…
-
CLINICAL_TRIALS trial_result · 2009-05-01Clinical Trial Update: Follow-up Study 16-20 Years After Primary Vaccination Against Hepatitis B of Newborns From HBeAg+ & HBsAg+ Mothers [Phase 4]
This Phase 4 follow-up study assesses long-term durability of protection 16-20 years after newborn vaccination against Hepatitis B in childr…
-
CLINICAL_TRIALS trial_result · 2009-04-27Clinical Trial Update: Efficacy and Safety of Clevudine Compared With Adefovir in Patients With HBeAg Positive Chronic Hepatitis Due to Hepatitis B Virus [Phase 3]
A Phase 3 trial comparing clevudine to adefovir in HBeAg-positive chronic hepatitis B has been terminated, with the study reporting on effic…
-
CLINICAL_TRIALS trial_result · 2009-04-27Clinical Trial Update: Efficacy and Safety of Clevudine Compared With Adefovir in Patients With Chronic Hepatitis Due to Hepatitis B Virus [Phase 3]
Phase 3 trial comparing clevudine with adefovir in chronic hepatitis B was terminated; the snippet does not provide efficacy or safety resul…
-
CLINICAL_TRIALS withdrawal · 2009-04-20Clinical Trial Update: Comparison of Telbivudine Versus Lamivudine on the Early Dynamics and Kinetics of Viral Suppression in Chronic Hepatitis B [Phase 4]
A Phase 4 clinical trial comparing telbivudine to lamivudine for chronic hepatitis B was withdrawn from the study status.
-
CLINICAL_TRIALS trial_result · 2009-04-14Clinical Trial Update: A Study of 2 Doses of a Hepatitis B Vaccine (V232 RECOMBIVAX HB) in Healthy Infants (V232-057) [Phase 3]
This is a Phase 3 trial evaluating two doses of the Hepatitis B vaccine (Recombivax HB) in healthy infants. The study has completed and post…
-
CLINICAL_TRIALS trial_result · 2009-04-06Clinical Trial Update: Risk of Hepatitis B Virus Reactivation in Patients Undergoing Allografting
This clinical trial update discusses the risk of hepatitis B virus reactivation in patients undergoing allogeneic transplantation. The trial…
-
CLINICAL_TRIALS trial_result · 2009-04-03Clinical Trial Update: A Efficacy and Safety Study of Adefovir Dipivoxil to Treat Chinese Patients With HBeAg+ve Chronic Hepatitis B [Phase 3]
Phase 3 efficacy and safety trial of adefovir dipivoxil in Chinese patients with HBeAg-positive chronic hepatitis B has completed.
-
CLINICAL_TRIALS trial_result · 2009-03-31Clinical Trial Update: Study of Recombinant Modified Process Hepatitis B Vaccine in Older Adults (V232-059)(COMPLETED) [Phase 3]
A completed Phase 3 trial evaluated a recombinant modified process Hepatitis B vaccine in older adults, with results posted in 2009.
-
CLINICAL_TRIALS trial_result · 2009-03-31Clinical Trial Update: Immuno & Safety Study of GSK Biologicals' Thio or Preservative Free Hepatitis B Vaccine in Subjects Aged 11-15 Yrs [Phase 3]
A Phase 3 trial update for a thio- or preservative-free hepatitis B vaccine in children aged 11-15 completed with results posted in 2009.
-
CLINICAL_TRIALS trial_result · 2009-03-17Clinical Trial Update: Assessing Antibody Responsiveness to Hepatitis B Vaccine in Aged Lymphoma Patients Undergoing Treatment With Rituximab [NA]
A clinical trial update assessing the antibody response to the Hepatitis B vaccine in older lymphoma patients undergoing rituximab therapy.
-
CLINICAL_TRIALS trial_result · 2009-03-12Clinical Trial Update: Early Response to Interferon Combined Short-Term Nucleoside Analogue Therapy in HBeAg(+) Chronic Hepatitis B [NA]
This is a clinical trial update reporting on early response to interferon combined with short-term nucleoside analogue therapy in HBeAg-posi…
-
FDA approval · 2009-02-25FDA Approved: BARACLUDE — Supplemental Application (E.R. Squibb & Sons, L.L.C.)
FDA approved a supplemental application for BARACLUDE (entecavir) submitted by E.R. Squibb & Sons, L.L.C.
-
FDA approval · 2009-02-25FDA Approved: BARACLUDE — Supplemental Application (E.R. Squibb & Sons, L.L.C.)
The FDA approved a supplemental application for BARACLUDE (entecavir) submitted by E.R. Squibb & Sons, L.L.C.
-
CLINICAL_TRIALS trial_result · 2009-02-18Clinical Trial Update: Efficacy and Safety of PegIFN +/- FTC / TDF to Treat Chronic Hepatitis B in HIV-Coinfected Patients [Phase 3]
Phase 3 trial evaluating the efficacy and safety of pegylated interferon alfa-2a with or without emtricitabine and/or tenofovir disoproxil f…
-
CLINICAL_TRIALS research · 2009-02-09Clinical Trial Update: The Risk of Exacerbation of Chronic Hepatitis B After Percutaneous Radiofrequency Ablation of Hepatocellular Carcinoma
A clinical trial update describes the risk of exacerbation of chronic hepatitis B after percutaneous radiofrequency ablation of hepatocellul…
-
CLINICAL_TRIALS research · 2009-02-09Clinical Trial Update: Efficacy of Antiviral Therapy After Radical Resection for Hepatitis B Virus-Related Hepatocellular Carcinoma [Phase 4]
An update on a Phase 4 trial evaluating antiviral therapy after radical resection of hepatitis B–related hepatocellular carcinoma; current s…
-
CLINICAL_TRIALS trial_result · 2009-02-06Clinical Trial Update: Evaluation of Serum Levels and Pharmacokinetics of a New Hepatitis B Immune Globulin Following Liver Transplantation [Phase 3]
Phase 3 trial update reporting on serum levels and pharmacokinetics of a new hepatitis B immune globulin in liver transplant patients.
-
CLINICAL_TRIALS trial_result · 2009-02-03Clinical Trial Update: Evaluation of Chronic HBV Patients w/Evidence of HBV Replication and Normal or Minimally Elevated Liver Transaminases.
This completed clinical trial evaluated chronic hepatitis B patients with HBV replication and normal or minimally elevated liver transaminas…